Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

HAE – Haemonetics Corporation

Haemonetics Corporation
HAE
$73.80
Name : Haemonetics Corporation
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $3,545,440,768.00
EPSttm : 3.31
finviz dynamic chart for HAE
Haemonetics Corporation
$73.80
1.30%
$0.97

Float Short %

8.57

Margin Of Safety %

2

Put/Call OI Ratio

0.51

EPS Next Q Diff

-0.07

EPS Last/This Y

1.54

EPS This/Next Y

0.77

Price

73.82

Target Price

93

Analyst Recom

1.27

Performance Q

14.94

Relative Volume

1.66

Beta

0.39

Ticker: HAE




19 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-06-02HAE68.810.940.803820
2025-06-03HAE69.660.910.283816
2025-06-04HAE69.690.980.003589
2025-06-05HAE70.460.980.993593
2025-06-06HAE70.460.980.143894
2025-06-09HAE71.690.680.334848
2025-06-10HAE72.210.680.864848
2025-06-11HAE71.590.684.734849
2025-06-12HAE71.310.684.734849
2025-06-13HAE70.10.67100.005004
2025-06-16HAE69.960.67100.005004
2025-06-17HAE69.010.730.005005
2025-06-18HAE70.090.730.005005
2025-06-20HAE71.110.737.435005
2025-06-23HAE72.080.511.282894
2025-06-24HAE73.070.520.002941
2025-06-25HAE73.410.520.002948
2025-06-26HAE74.840.511.332968
2025-06-27HAE73.830.510.002974
DateSymbolLastP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-06-02HAE68.81-0.114.84.87
2025-06-03HAE69.66-0.114.24.87
2025-06-04HAE69.67-0.111.94.87
2025-06-05HAE70.40-0.113.84.87
2025-06-06HAE70.47-0.112.04.87
2025-06-09HAE71.65-0.115.04.87
2025-06-10HAE72.21-0.113.34.87
2025-06-11HAE71.60-0.110.54.87
2025-06-12HAE71.36-0.111.54.87
2025-06-13HAE70.09-0.18.64.87
2025-06-16HAE69.97-0.111.64.87
2025-06-17HAE69.03-0.19.44.87
2025-06-18HAE70.06-0.114.74.87
2025-06-20HAE71.08-0.114.54.87
2025-06-23HAE72.02-0.114.34.87
2025-06-24HAE73.08-0.114.54.87
2025-06-25HAE73.46-0.112.94.87
2025-06-26HAE74.80-0.115.34.87
2025-06-27HAE73.82-0.19.54.87
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-06-02HAE0.00-4.698.59
2025-06-03HAE0.00-4.698.59
2025-06-04HAE0.00-4.698.59
2025-06-05HAE0.00-4.698.59
2025-06-06HAE0.00-4.698.59
2025-06-09HAE0.00-4.318.60
2025-06-10HAE0.00-4.318.60
2025-06-11HAE0.00-4.318.69
2025-06-12HAE0.00-4.318.69
2025-06-13HAE0.00-4.318.69
2025-06-16HAE0.00-4.288.69
2025-06-17HAE0.00-4.288.69
2025-06-18HAE0.00-4.288.69
2025-06-20HAE0.00-4.288.69
2025-06-23HAE0.00-4.288.69
2025-06-24HAE0.00-4.288.69
2025-06-25HAE0.00-4.288.69
2025-06-26HAE0.00-4.288.57
2025-06-27HAE0.00-4.288.57
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

1.24

Avg. EPS Est. Current Quarter

1.02

Avg. EPS Est. Next Quarter

1.17

Insider Transactions

Institutional Transactions

-4.28

Beta

0.39

Average Sales Estimate Current Quarter

305

Average Sales Estimate Next Quarter

321

Fair Value

75.05

Quality Score

85

Growth Score

92

Sentiment Score

90

Actual DrawDown %

48.1

Max Drawdown 5-Year %

-68.6

Target Price

93

P/E

22.25

Forward P/E

13.12

PEG

1.98

P/S

2.61

P/B

4.34

P/Free Cash Flow

24.89

EPS

3.32

Average EPS Est. Cur. Y​

4.87

EPS Next Y. (Est.)

5.64

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

12.32

Relative Volume

1.66

Return on Equity vs Sector %

-3.5

Return on Equity vs Industry %

2

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.04

EBIT Estimation

9.5
Haemonetics Corporation
Sector: Healthcare
Industry: Medical Devices
Employees: 3023
Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 tools. It also provides treatment in electrophysiology, critical care, neurocritical care, trauma, burn surgery, spine surgery, and cancer surgery; SavvyWire, a sensor-guided 3-in-1 guidewire for TAVR procedures; and OptoWire, a pressure guidewire that measures fractional flow reserve and diastolic pressure ratio, as well as fiber optic sensor solutions used in medical devices and other critical industrial applications. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE closure products comprising VASCADE 5F, VASCADE 6/7F, VASCADE MVP XL, and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, clinical specialists, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.
stock quote shares HAE – Haemonetics Corporation Stock Price stock today
news today HAE – Haemonetics Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch HAE – Haemonetics Corporation yahoo finance google finance
stock history HAE – Haemonetics Corporation invest stock market
stock prices HAE premarket after hours
ticker HAE fair value insiders trading